Healthcare & Life Sciences
Epirium Bio
United Statesepirium.com/
Epirium Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Epirium Bio
Based in the United States, Epirium Bio is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Epirium Bio develops orally bioavailable small molecule therapies targeting PGE-2 signaling to treat neuromuscular, inflammatory, and fibrotic diseases, with its lead compound MF-300 currently in Phase 2b trials for sarcopenia.
Explore Epirium Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.